Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 20, 2025
Anti-CGRP monoclonal antibodies, migraine and mood disorders: an observational studyMarco Bolchini, Giulia Ceccardi, Francesca Schiano di Cola, et al.
European Neurology|December 20, 2022
Migraine Disability and Severity Improvement during Long-Term Treatment with ErenumabMarco Bolchini, Francesca Schiano di Cola, Giulia Ceccardi, et al.
Frontiers in Neurology|February 6, 2023
Photophobia and migraine outcome during treatment with galcanezumabFrancesca Schiano di Cola, Giulia Ceccardi, Marco Bolchini, et al.
European Journal of Neurology|March 1, 2023
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptorFrancesca Schiano di Cola, Marco Bolchini, Giulia Ceccardi, et al.
Neurology International|February 22, 2023
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic MigraineFrancesca Schiano di Cola, Marco Bolchini, Salvatore Caratozzolo, et al.
European Journal of Neurology|January 2, 2024
Increased risk of functional neurological disorders following SARS-CoV-2 vaccinationAndrea Pilotto, Marcello Catania, Irene Mattioli, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|November 25, 2022
Post COVID-19 vaccination headache: A clinical and epidemiological evaluationGiulia Ceccardi, Francesca Schiano di Cola, Marco Di Cesare, et al.
Journal of Neurology|February 24, 2026
Could galcanezumab modulate inflammatory cytokines? A single-centre exploratory studyGiulia Ceccardi, Renata Rao, Francesca Schiano di Cola, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 24, 2025
Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control studyEleonora Colombo, Alberto Doretti, Renata Rao, et al.
Pageof 1